文献速递肿瘤 PET/CT

子宫内膜癌[18F]FDG PET/CT肿瘤分割方法的优化:实现可重复的代谢肿瘤体积量化

Toward reproducible metabolic tumor volume quantification in endometrial cancer: optimizing [¹⁸F]FDG PET/CT tumor segmentation methods.
PubMed 文献 · EJNMMI Res · 2026-05-28

本研究纳入146例组织学确诊的子宫内膜癌患者,术前接受PET/CT,评估不同阈值法勾画代谢肿瘤体积(MTV)的观察者间一致性、与MRI解剖肿瘤体积的相关性及预测侵袭性疾病的价值。结果显示MTV2.5可重复性极佳(ICC 0.97),MTV2.5与MTV20-50%预测效能相似,支持其临床用于术前评估。

要点

  • MTV2.5观察者间可重复性极佳(ICC 0.97)。
  • 固定2.5阈值与相对SUVmax阈值均与解剖体积强相关。
  • MTV2.5与MTV20-50%预测侵袭性疾病的AUC相似。

核心结论

  • MTV2.5具有极佳的可重复性并与解剖体积相关性良好。
  • MTV2.5与MTV20-50%阈值对侵袭性疾病特征的预测效能相似,支持其用于子宫内膜癌术前评估的临床实施。

研究设计与样本

  • 本研究纳入146例组织学确诊的子宫内膜癌患者,术前接受PET/CT成像(Siemens TruePoint n=67;Siemens Biograph Vision n=79)。
  • 研究评估了MTV勾画的观察者间一致性、不同阈值法MTV与MRI解剖肿瘤体积(ATV)的相关性,以及预测侵袭性疾病的价值。

主要发现

  • MTV2.5(SUV阈值大于2.5)观察者间ICC(95%CI)为0.97(0.96, 0.98)。
  • MTV40%(SUV大于SUVmax的40%)ICC(95%CI)为0.91(0.87, 0.93)。
  • 固定2.5阈值与所有相对SUVmax阈值(20-60% SUVmax)所得MTV与ATV强相关,Spearman秩相关系数范围0.806至0.874(p < 0.001)。
  • MTV30%与ATV体积最接近,中位差异(95%CI)为-4%(-11%, 2%)。
  • MTV2.5与MTV20-50%预测淋巴结转移、晚期FIGO分期(III-IV)及3年疾病特异性生存的AUC(95%CI)范围0.68(0.53, 0.82)至0.77(0.65, 0.88);MTV60%的AUC(95%CI)范围0.64(0.49, 0.80)至0.72(0.63, 0.82)。

关键数值与推荐

  • MTV2.5阈值定义为SUV大于2.5。
  • 相对阈值定义为SUV大于SUVmax的20%至60%。
  • MTV2.5观察者间ICC为0.97(0.96, 0.98),MTV40%为0.91(0.87, 0.93)。
  • MTV2.5与MTV20-50%预测侵袭性疾病的AUC范围为0.68(0.53, 0.82)至0.77(0.65, 0.88)。

临床怎么用

  • 在子宫内膜癌术前评估中,可采用MTV2.5进行代谢肿瘤体积量化,因其可重复性极佳且与解剖体积相关性好。
  • MTV2.5与MTV20-50%阈值预测侵袭性疾病效能相似,可根据临床习惯选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Metabolic tumor volume (MTV) derived from [18F]FDG PET/CT has shown promise in improving preoperative staging and prognostication in endometrial cancer, both as a standalone biomarker and as a foundation for PET-based tumor radiomics. Despite its potential, standardized segmentation methods are lacking. This study aimed to (1) evaluate interobserver agreement in MTV delineation, (2) compare MTVs obtained through various thresholding approaches by examining their correlation with anatomical tumor volume (ATV) from MRI, and (3) assess their value for predicting aggressive disease. RESULTS: This study included 146 patients with histologically confirmed endometrial cancer who underwent preoperative PET/CT imaging on a Siemens TruePoint (n = 67) or a Siemens Biograph Vision scanner (n = 79). MTV2.5 defined by a standardized uptake value (SUV) threshold larger than 2.5, demonstrated excellent reproducibility between readers, with an intraclass correlation coefficient (95% confidence interval (CI)) of 0.97 (0.96, 0.98). MTV40%, defined by SUV > 40% of SUVmax, yielded an ICC (95% CI) of 0.91 (0.87, 0.93). Both the fixed 2.5 threshold and all relative SUVmax-based thresholds (20-60% SUVmax) produced MTVs with strong correlation to ATV, with Spearman's rank correlation coefficients ranging from 0.806 to 0.874 (p < 0.001). The closest volumetric match to ATV was observed for MTV30%, with a median difference (95% CI) of -4% (-11%, 2%). In terms of predictive performance, MTV2.5 and MTV20-50% yielded comparable results for predicting lymph node metastases, advanced FIGO stage (III-IV), and 3-year disease specific survival, with area under receiver operating characteristic curve (AUC) values (95% CI) ranging from 0.68 (0.53, 0.82) to 0.77 (0.65, 0.88). MTV60% showed slightly lower prediction values across all outcomes, with AUCs (95% CI) between 0.64 (0.49, 0.80) and 0.72 (0.63, 0.82). CONCLUSION: MTV2.5 has excellent reproducibility and correlates well with anatomical volume. Both MTV2.5 and MTV20-50% thresholds yield similar performances for predicting aggressive disease features, supporting their potential for clinical implementation in preoperative assessment of endometrial cancer.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Fasmer KE, Lindås S, Gulati A, et al. Toward reproducible metabolic tumor volume quantification in endometrial cancer: optimizing [¹⁸F]FDG PET/CT tumor segmentation methods. EJNMMI Res. 2026. PMID: 42209943. doi:10.1186/s13550-026-01412-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。